Home/Filings/4/0001140361-18-009162
4//SEC Filing

LUDWIG DAVID F 4

Accession 0001140361-18-009162

CIK 0000009326other

Filed

Feb 19, 7:00 PM ET

Accepted

Feb 20, 6:15 PM ET

Size

9.9 KB

Accession

0001140361-18-009162

Insider Transaction Report

Form 4
Period: 2018-02-15
LUDWIG DAVID F
VP/Gen Mgr/ARC Spec Prods
Transactions
  • Award

    Common Stock

    2018-02-15+93031,486 total
  • Award

    Common Stock

    2018-02-15+2,71934,205 total
  • Tax Payment

    Common Stock

    2018-02-15$74.57/sh1,381$102,98132,824 total
  • Award

    Stock Option

    2018-02-15+3,7203,720 total
    Exercise: $74.57Exp: 2028-02-15Common Stock (3,720 underlying)
Footnotes (4)
  • [F1]Ownership of the restricted stock does not vest in Reporting person until four years from the grant date and is further subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person.
  • [F2]Acquired upon the settlement of performance shares granted on February 19, 2018 based upon a predetermined EBITDA performance target and total shareholder return against the Russell 2000 Index over a three-year period under the Company's Second Amended and Restated 1999 Stock Plan (as amended and restated effective June 20, 2013) as a result of the satisfaction of those performance criteria.
  • [F3]1,381 of the 2,698 shares that vested February 15, 2018 were withheld to cover withholding taxes due upon vesting.
  • [F4]Options vest 20% year 1; 40% year 2; and 40% year 3.

Issuer

BALCHEM CORP

CIK 0000009326

Entity typeother

Related Parties

1
  • filerCIK 0001209495

Filing Metadata

Form type
4
Filed
Feb 19, 7:00 PM ET
Accepted
Feb 20, 6:15 PM ET
Size
9.9 KB